BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 58.06 -0.45 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.51 | 52 Week High | $108.96 | |||
| Open | $58.66 | 52 Week Low | $62.12 | |||
| Day High | $59.51 | P/E | N/A | |||
| Day Low | $57.70 | EPS | $-1.27 | |||
| Volume | 994,707 | |||||
